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Pim1 kinase protects airway epithelial cells from 
cigarette smoke-induced damage and airway 
inflammation
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Abstract
Exposure to cigarette smoke (CS) is the main risk factor for developing 
chronic obstructive pulmonary disease and can induce airway epithelial 
cell damage, innate immune responses, and airway inflammation. We 
hypothesized that cell survival factors might decrease the sensitivity of 
airway epithelial cells to CS-induced damage, thereby protecting the 
airways against inflammation upon CS exposure. Here, we tested whether 
Pim survival kinases could protect from CS-induced  inflammation. We 
determined expression of Pim kinases in lung tissue, airway inflammation 
and levels of Keratinocyte-derived Cytokine and several damage-
associated molecular patterns in bronchoalveolar lavage in mice exposed 
to CS or air. Human bronchial epithelial BEAS-2B cells were treated with 
CS extract (CSE) in presence or absence of Pim1 inhibitor and assessed 
for loss of mitochondrial membrane potential, induction of cell death, 
and release of HSP70. We observed increased expression of Pim1, but 
not of Pim2 and Pim3, in lung tissue after exposure to CS. Pim1-deficient 
mice displayed a strongly enhanced neutrophilic airway inflammation 
upon CS exposure compared with wild-type controls. Inhibition of Pim1 
activity in BEAS-2B cells increased the loss of mitochondrial membrane 
potential and reduced cell viability upon CSE treatment, whereas release 
of HSP70 was enhanced. Interestingly, we observed release of S100A8 but 
not of double-stranded DNA or HSP70 in Pim1-deficient mice compared 
with wild-type controls upon CS exposure. In conclusion, we show that 
expression of Pim1 protects against CS-induced cell death in vitro and 
neutrophilic airway inflammation in vivo. Our data suggest that the 
underlying mechanism involves CS-induced release of S100A8 and KC.
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2
Introduction
Worldwide, ~10 percent of the population is suffering from chronic 
obstructive pulmonary disease (COPD), a respiratory disease with 
increasing morbidity and mortality [1][2]. COPD is characterized by a not 
fully reversible reduction of the airflow and an abnormal inflammatory 
response to cigarette smoke (CS) in the small airways and alveoli. This 
response is manifested by chronic neutrophilic inflammation and is 
thought to contribute to remodeling of the airways, which leads to 
thickening of the airway wall and subsequent decrease in the diameter of 
the airways [1][3]. In the Western world, exposure to CS is the main risk 
factor for the development of COPD [1]. Consequently, exposure to CS and 
the subsequent tissue damage in the airways is a topic of high interest in 
COPD research.
CS contains > 4,000 chemicals and can activate the innate immune 
system via pattern recognition receptors such as Toll like receptors (TLRs). 
Short-term CS exposure has indeed been shown to induce neutrophilic 
airway inflammation both in mouse models and in human subjects [4]
[5][6]. Activation of TLRs on airway epithelial cells upon CS exposure is 
known to result in the release of pro-inflammatory cytokines [7], followed 
by an influx of inflammatory cells like neutrophils and monocytes, which 
also has been found to be TLR and MyD88 dependent [8][9]. CS-induced 
airway inflammation might be the result of direct activation of TLRs by 
CS components, including lipopolysaccharide, or be the consequence of 
damage and death of airway epithelial cells induced by the toxic components 
of CS [10]. Interestingly, CS exposure has been shown to predispose to 
necrotic cell death in vitro [11][12][13][14], which can contribute to the 
induction of an innate immune response and inflammation through the 
release of damage-associated molecular patterns (DAMPs) [10][15]. 
Therefore, we hypothesized that factors regulating cell survival could play 
a role in the sensitivity to the innate inflammatory response induced by 
CS exposure. However, the underlying mechanisms and the relevance 
of cell survival pathways for the response of airway epithelial cells to CS 
exposure are still relatively unknown.
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One family of proteins well-known to be involved in the regulation 
of cell survival is the Pim serine/threonine kinase family. Pim kinases 
were originally identified as protooncogenes and are associated with 
the transcriptional regulation of cell cycle proteins [16]. Pim kinases 
are constitutively active and regulate cell growth, differentiation and 
apoptosis [16]. There are three Pim kinase family members, of which Pim1 
is best characterized. Pim1 can have marked anti-apoptotic effects, and 
is for instance able to counter the induction of apoptosis associated with 
increased Myc activity during transformation of lymphoid cells [17]. One 
of the best-studied mechanisms by which Pim1 can exert its prosurvival 
activity is the phosphorylation of the BCL-2-associated agonist of cell 
death (BAD) on the mitochondrial membrane, thereby increasing the 
threshold for apoptosis [18]. Interestingly, Pim1 is strongly expressed in 
bronchial epithelium [19]. Bronchial epithelial cells form a continuous size- 
and ion-selective physical barrier, lining the airway lumen and preventing 
the entry of inhaled toxic substances, including CS components, in the 
submucosal tissues. Furthermore, bronchial epithelial cells also govern 
the innate immune responses to inhaled substances [20]. The functional 
consequences of Pim kinase expression for survival and the functional 
capacities of bronchial epithelial cells, however, are to date unknown.
In this study we aim to test the role for Pim survival kinases in the 
airway epithelium upon CS-induced damage and the consequences for 
the generation of an innate inflammatory response to CS in vivo.
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Materials and Methods
Animals
Female BALB/cByJ mice (6-8 wk) were purchased from Charles River 
Laboratories. Female Pim1-deficient and -proficient FVB/Nrcl mice 
(8-14 wk) were obtained from the Netherlands Cancer Institute 
(Amsterdam, The Netherlands). Mice were kept under specific pathogen-
free conditions in individually ventilated cages and maintained on a 12:12-
h light/dark cycle, with food and water ad libitum. Animal housing and 
experiments were performed after ethical review by and written approval 
of the Institutional Animal Care and Use Committee of the University of 
Groningen, The Netherlands.
CS exposure model
Mice were whole body exposed to gaseous-phase CS from Kentucky 
3R4F research-reference filtered cigarettes (Tobacco Research Institute, 
University of Kentucky, Lexington, KY) two times a day for 4 or 5 days, 
schematically depicted in Figs. 1A and 2A. Each cigarette was smoked 
without filter in 5 min using the Watson Marlow 323E/D smoking pump at 
a rate of 5 l/hour (Watson-Marlow BV, Rotterdam, The Netherlands). By 
mixing in ambient air at a rate of 60 L/hours, a smoke-to-air ratio of 1:12 
was obtained. The CS and air were directly distributed inside 6-liter Perspex 
boxes by silicone tubes (bore 4.8 mm/wall 1.6mm) (Watson-Marlow). 
During the smoke experiment, the diet of all animals was supplemented 
with soluble food (RMH-B flour, AB Diets, Woerden, The Netherlands). 
Mice were killed at indicated time points, and bronchoalveolar lavage 
(BAL) fluid, blood, and lung tissue was collected.
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Collection of BAL fluid
Immediately after bleeding, lungs were lavaged through a tracheal 
cannula with 1 ml PBS containing 3% BSA (Sigma Aldrich, Zwijndrecht, 
The Netherlands) and Complete Mini Protease Inhibitor Cocktail (Roche 
Diagnostics, Basel, Switzerland). Cells were pelleted, and supernatant 
was stored at -80 °C for further measurement of cytokines and DAMPs 
by ELISA. Lavage was repeated four times with 1-ml aliquots of PBS. After 
pooling of the cells, total BAL cell numbers were counted with a Coulter 
Counter and cytospin preparations were made.
For the preparation of single cell suspensions, lungs were collected 
in PBS containing 1% BSA and sliced into a homogenous suspension. 
The cell suspension was incubated in RPMI containing 1% BSA,
4 mg/ml Collagenase A (Roche Diagnostics) and 0.1 mg/ml DNAse 1 
(Roche Diagnostics) at 37 ⁰C for 1 h. After incubation, cells were filtered 
through a 70-µM Falcon cell strainer (BD biosciences, San Jose, CA) and 
pelleted by centrifugation. Red blood cells were lysed in 1 ml lysis buffer 
for 5 min at room temperature and resuspended in 200 µl PBS containing 
1% BSA. Total cell numbers were determined using a Coulter Counter and 
cytospin preparations were made.
Single cell suspension analysis of BAL fluid and lung tissue
To analyze the cellular composition in the single cell suspensions of lung 
tissue (Fig. 1) and BAL fluid (Fig. 2), cytospin preparation were stained 
with Diff-Quick (Merz & Dade, Dudingen, Switzerland) and evaluated in a 
blinded fashion. Cells were identified and differentiated into mononuclear 
cells, neutrophils and eosinophils by standard morphology. At least 300 
cells were counted per cytospin preparation.
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The levels of Keratinocyte-derived cytokine (KC), S100A8 and heat 
shock protein 70 (HSP70) in the BAL fluid were determined by ELISA, 
according to the manufacturer’s instructions (R&D systems, Abingdon, 
United Kingdom for KC and HSP70 and Uscn Life Science, Wuhan, China, for 
S100A8). BAL levels of double-strand DNA (dsDNA) were measured using 
the Quant-iT Picogreen dsDNA Assay kit (Invitrogen Life Technologies, 
Carlsbad, CA) according to manufacturer’s protocol.
Preparation of lung tissue sections
Lungs were treated as previously described [21]. Briefly, lungs were inflated 
with TissueTek OCT Compound (Sakura Finetek Europe, Zouterwoude, 
The Netherlands), fixed in 10% Formalin for 24 h, embedded in paraffin, 
and cut in 3-µm-thick sections.
Immunohistochemistry of Pim1 kinase
Lung sections were deparaffinized in xylene, dehydrated in ethanol, and 
washed in PBS. Antigen retrieval was performed by heating lung sections 
to the boiling point in 1 mM EDTA for 15 minutes. Sections were then 
washed with PBS and blocked with PBS containing 30% H2O2 for 30 min. 
Lung sections were immunostained with goat-anti-Human Pim1 (E16; 
1:800; Santa Cruz Biotechnology, Heidelberg, Germany) for 1 h, followed 
by incubation with the secondary Ab (1:100; rabbit-anti-goat-HRP; DAKO, 
Glostrup, Denmark) and the tertiary Ab (1:100; goat-anti-rabbit-HRP; 
DAKO). The immunostains were developed by using DAB substrate and 
mounted with a glass slide using Kaiser’s glycerine (Life Technologies 
Europe, Bleiswijk, The Netherlands).
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TUNEL Staining
The DeadEnd Fluorometric TUNEL System (Promega Benelux, Leiden, 
The Netherlands) was used to detect apoptotic cells according to the 
manufacturer’s instructions. Briefly, lung sections were deparaffinized 
in xylene, dehydrated in ethanol, washed in PBS, and fixed in 4% 
paraformaldehyde in PBS for 15 min. After being washed, tissue was 
permeabilized with 20 µg/ml proteinase K solution for 10 min at room 
temperature and fixed for a second time in 4% paraformaldehyde. For 
the DNase I positive control, tissue sections were incubated with 10 U/
ml of DNase I for 10 min at room temperature. Next, tissue sections 
were incubated with the terminal deoxynucleotidyl transferase reaction 
mixture for 1 h at 37 °C and counterstained with DAPI nuclear stain. Tissue 
sections were analyzed with fluorescence microscopy.
RNA isolation, reverse transcription and RT-qPCR
Total RNA was extracted from mice lung tissue for examining the expression 
of Pim1, Pim2 and Pim3. RNA was isolated by homogenizing 50-100 mg 
mouse lung tissue in 1 ml TriReagent (MRC, Cincinnati, OH). gDNA traces 
were enzymatically removed, and the RNA was purified with RNeasy Mini 
Kit (QIAGEN Benelux, Venlo, The Netherlands). The RNA concentration 
and integrity was determined by Nanodrop measurements (ND-1000 
spectrophotometer, Isogen Lifesciences, de Meern, The Netherlands).
Reverse transcription was performed with 2 µg RNA in 20 µl reaction 
volume using Omniscript reverse transcriptase (QIAGEN Benelux). The 
expression levels were measured using ABI primer-probe sets (Applied 
Biosystems Europe, Nieuwekerk a/d IJssel, The Netherlands) with 25 ng 
cDNA template. The following Gene Expression Assays were used: Pim1 
(Mm00435712_m1), Pim2 (Mm00454579_m1), Pim3 (Mm00446876_
m1). The gene expression was related to the most stable housekeeping 
gene of the three housekeeping genes B2M (Mm00437762_m1), Pgk1 
(Mm01225301_m1) and Hprt1 (Mm01545399_m1). The data was 
analyzed using SDS2.1 software.
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The most stable housekeeping gene for normalization was determined 
by using the Normfinder algorithm [22]. To obtain the relative expression, 
the cycle threshold value (Ct value) was subtracted from the Ct  value 
of the Pim assays. The Ct values were normalized to the average of   the 
control group, and the individual Ct values were then converted to relative 
expression levels.
Cell cultures
The human bronchial epithelial cell line BEAS-2B lung was purchased from 
American Type Culture Collection   (ATCC,   Manassas,   VA).   Cells   were 
grown   in   RPMI   1640   with   L-glutamin    and 25 mM HEPES (Lonza, Basel, 
Switzerland) supplemented with 10% heat-inactivated fetal bovine serum 
(Hyclone Thermo Scientific, Cramlington, UK) and 60 µg/ml Gentamycin 
(Lonza), or 100 U/ml Penicillin and 100 µg/ml streptomycin (Gibco, Life 
Technologies Europe, Bleiswijk, The Netherlands) until confluence. Before 
the experiments, cells were serum starved for 16 h in serum-free RPMI 
1640 medium and incubated with 5 µM Pim1 inhibitor K00135 [23] (kindly 
provided by dr. Juerg Schwaller, Department of Research, University 
Hospital Basel, Switzerland,) or vehicle (DMSO; Sigma-Aldrich, Steinheim, 
Germany) for the duration of the experiment.
Preparation of CSE
Kentucky 3R4F research-reference filtered cigarettes (Tobacco Research 
Institute) were  smoked using the Watson Marlow 603S smoking pump 
at a rate of 8 L/h (Watson-Marlow). Before use, the filters   were   cut 
from   the   cigarettes.   Each   cigarette   was   smoked   in   5   min    with 
a 17-mm butt remaining. The gaseous-phase CS of two cigarettes was led 
through 25 ml of RPMI 1640 medium without FCS, and this solution was 
set at 100% CS extract (CSE).
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Detection of mitochondrial membrane potential
A confluent layer of serum-depleted BEAS-2B cells was incubated for 
4 h with 0, 10, 15, 20, 30 or 40% CSE in the presence of 5 µM Pim1 
inhibitor K00135 [23] or DMSO. Thereafter, cells were washed two 
times with RPMI 1640 and stained with 500 nM TMRE (Molecular 
Probes, Life Technologies Europe, Bleiswijk, The Netherlands) for 
30 min at 37°C. After the staining, the cells were washed one time
with RPMI 1640, trypsinated and collected in FACS tubes. Cells were 
resuspended in 300 µl colorless DPBS complemented with calcium, 
magnesium, glucose and pyruvate (Gibco, Life Technologies Europe) and 
the mitochondrial membrane potential (Ψm) was measured using a BD 
FACSCalibur (BD biosciences). Data was analyzed using Winlist software.
Detection of cell death
A confluent layer of serum-depleted BEAS-2B cells was incubated for 4 h 
with 0, 10, 15, 20, 25, 30 or 40% CSE in the presence of 5 µM Pim1 inhibitor 
K00135 or DMSO [23]. After the incubation, cells were washed, trypsinated 
and collected in FACS tubes and washed twice with ice-cold Cell Staining 
Buffer (Biolegend, San Diego, CA). Thereafter, cells were resuspended 
in 100 µl annexin V Binding buffer (Biolegend) and incubated with 2.5 
µg/ml 7-amino-actinomycin and 1.25 µg/ml FITC annexin V (Biolegend) 
for 15 min at room temperature protected from light. Another 100 µl 
annexin V Binding buffer was added and the cells were measured with 
the BD FACSCalibur (BD Biosciences). Data were analyzed using Winlist 
software.
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Release of HSP70 in BEAS-2B cells
A confluent layer of serum-depleted BEAS-2B cells was incubated for 4 h 
with 0, 15 and 40% CSE in the presence of 5 µM Pim1 inhibitor or vehicle 
[23]. After incubation, cells were washed two times with RPMI 1640 and 
cultured for another 20 h with RPMI 1640 supplemented with 10% FCS. 
The supernatant was collected and stored at -80 °C until further analysis 
after spinning down the cellular components. The levels of HSP70 were 
determined by ELISA, according to the manufacturer’s instructions (R&D 
systems).
Statistical analysis
The Mann-Whitney U-test was used to test for statistical significance 
between groups in the in vivo experiments. Correlation between KC levels 
in BAL fluid and numbers of neutrophils in BAL were calculated with 
Pearson correlation coefficient. To test the statistical significance of the in 
vitro experiments, two-way ANOVA was used for the mitochondrial Ψm 




CS induces the expression of Pim1 kinase
To assess the role of Pim family kinases in CS-induced neutrophilic airway 
inflammation, we first studied the expression of the three Pim kinases 
in a short-term model of repeated exposure to CS, which is known to 
induce such an inflammatory response [6][9][24]. Because Pim kinases 
are typically early-response genes with a short half-life of both mRNA and 
protein [16], we included a series of time points for the measurement of 
Pim expression levels after the repeated CS exposures. We exposed BALB/
cByJ mice to CS for 4 days and killed the mice 16 h after the last CS exposure 
or 2, 4 and 6 h after a next CS exposure on the 5th day (see Fig. 1A).
To confirm the induction of neutrophilic airway inflammation by the CS 
exposure,  we examined the fraction of neutrophilic granulocytes present 
in lung tissue. We observed a significant increase in the percentage of 
neutrophils in the lung tissue of mice exposed to CS compared with air 
control-treated mice (Fig. 1B). The percentage of neutrophils was the 
highest in mice exposed to CS for 4 days and sacrificed 16 h after the last 
CS exposure. Moreover, subsequent CS exposure on day 5 and killing of the 
mice 2, 4 and 6 h after this last CS exposure also resulted in a significantly 
increased number of neutrophils compared to air control-treated mice, 
although no further increase compared to the 4-day CS exposure was 
observed (Fig. 1B).
Neutrophilic airway inflammation in CS exposure models is often 
associated with increased levels of the proinflammatory cytokine and 
neutrophil attractant KC (mouse analog of IL-8) in BAL fluid [4]. Hence, we 
tested the KC levels in BAL upon CS exposure and observed a significant 
increase in KC levels in mice exposed to CS compared to air control-
treated mice at all time points tested (Fig. 1C). The highest levels of KC 
were observed in mice exposed to CS for 4 days and killed 16 h later and 
in mice sacrificed 6 h after the last smoke exposure on day 5.
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Figure 1: Cigarette smoke (CS) induces the expression of Pim1 kinase
Female BALB/cByJ mice were exposed to CS for 4 days and killed 16 h after the last smoke 
exposure or exposed to CS or air for 5 days and killed 2, 4 or 6 h after the last CS exposure 
(A). Lung tissue was analyzed for the present of neutrophilic granulocytes by standard 
morphology evaluation of single cell suspension in cytospin preparations (B), and the 
released amount of keratinocyte-derived cytokine (KC) was measured in bronchial alveolar 
fluid (C). The expression of Pim1 (D), Pim2 (E) and Pim3 (F) in lung tissue was determined 
with RT-qPCR. Each group consisted of 8 mice. For the detection of the neutrophilic 
granulocytes in the air-control treated and mice harvested 6h after the last CS exposure, 
only lung tissue of, respectively, 7 and 6 mice was available. The median of the groups is 
presented. * P < 0.05, ** P < 0.01 and *** P < 0.001 compared with air control-treated 
mice.
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In summary, this subchronic model of CS exposure induced neutro-
philic airway inflammation in BALB/cByJ mice. Next, we analyzed the 
mRNA expression levels of Pim1, Pim2, and Pim3 in whole lung tissue 
in CS-exposed and air control-treated mice (Fig. 1D, E and F). For Pim1, 
we observed a significantly increased expression in mice sacrificed 2 h 
after the last CS exposure, as would be expected for an early response 
gene. At all other time points, Pim1 expression levels were similar to 
air control-treated mice. No differences were found in the expression 
of Pim2 and Pim3 upon CS exposure for all the different time points.
These results demonstrate that expression of Pim1, but not Pim2 and 
Pim3, is transiently induced in lung tissue shortly after CS exposure.
Pim1 deficiency sensitizes CS-induced neutrophilic airway inflammation
To assess whether Pim1 expression affects the CS-induced inflammatory 
response, we used Pim1-proficient and -deficient mice on an FVB/Crln 
background and exposed the mice to CS in our subchronic CS exposure 
model. Based on our results in Fig. 1, in which we observed high 
percentages of neutrophils and high levels of KC on day 5 of the protocol, 
16 h after the last smoke exposure on day 4, we killed the mice at this 
specific time point (see Fig. 2A) to have an optimal range between CS-
exposed and air control-treated animals for the detection of differences 
between Pim1-proficient and -deficient mice.
As shown in Fig. 2B, CS exposure of Pim1-deficient mice or wild-type 
controls resulted in increased total cell numbers in BAL fluid, independent 
of genotype. The differential cell counts in BAL from CS- and air-exposed 
mice revealed the same pattern for the number of mononuclear cells 
between Pim1-deficient mice and wild-type controls (Fig. 2C).
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Fig. 2: Pim1 deficiency sensitizes the CS-induced neutrophilic airway inflammation
Female FVB/Nrcl mice proficient (WT) or deficient (KO) for Pim1 kinase were exposed to 
CS or air for 4 days and killed 16 h after the last smoke exposure (A). The bronchoalveolar 
fluid was analyzed for the total cell cumber (B), the number of mononuclear cells (C), the 
number of neutrophils (D) and the released amount of KC (E). The correlation between 
the number of neutrophilic granulocytes and levels of KC in BAL was analyzed for all the 
experimental groups of mice (F) and for the Pim1-deficient exposed to CS only (G). The 
lower limit of detection for the mononuclear cells and neutrophils was set on 100 cells, 
based on the total cell count. Each group consisted of 8 mice. The median of the groups is 
presented. * P < 0.05, ** P < 0.01, and *** P < 0.001.
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Strain differences in CS-induced neutrophilic airway inflammation 
have been described before [25][26][27]. Indeed, the FVB/Crln strain 
was far less sensitive to develop neutrophilic airway inflammation than 
the BALB/cByJ strain, since the wild-type mice displayed relatively low 
numbers of neutrophils in their BAL (Fig. 2D). In contrast to their wild-
type counterparts, Pim1-deficient mice on an FVB/Crln background 
did show a significant influx of neutrophilic granulocytes upon the 
subchronic CS exposure (Fig. 2D). Furthermore, we analyzed the levels 
of the proinflammatory chemokine KC in BAL fluid of these mice. Here, 
we observed a trend (p=0.083) toward an increased release of KC in the 
BAL of CS-exposed Pim1-deficient mice compared to the CS-exposed wild-
type mice (Fig. 2E). Because the KC levels were showing merely a trend 
toward an increase in CS-exposed Pim1-deficient mice, we next assessed 
the correlation between KC levels and numbers of neutrophils in the CS-
exposed mice, both in all CS exposed mice and within the Pim1-deficient 
mice only (Fig. 2F). Here, we observe a strong (r2=0.64), significant 
(P=0.016) correlation between KC levels and numbers of neutrophils in 
BAL in CS-treated Pim1-deficient mice, suggesting that the differences in 
KC levels between CS-treated Pim1-deficient mice explained the observed 
variation in the number of BAL neutrophils between the individual mice.
Importantly, these data show that Pim1-deficient mice are more 
susceptible than Pim1-proficient wild-type control mice for neutrophilic 
airway inflammation upon CS exposure.
CS exposure enhances Pim1 expression in the airway epithelium
Next, we aimed to validate previous data in the literature that Pim1 is 
expressed in airway epithelial cells [19]. To this end, we stained for 
Pim1 by immunohistochemistry in lung tissue from Pim1-proficient and 
-deficient mice (as control) on an FVB/Crln background. To validate our 
observation of increased Pim1 expression after CS exposure, we also 
compared this staining between lung tissue sections from air control-
treated mice and CS-treated mice. As shown in Fig. 3, Pim1 expression is
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largely confined to the airway epithelium, with occasional cells in the lung 
parenchyma also staining for Pim1. In CS-exposed mice, Pim1 expression in 
airway epithelium seems to be slightly increased over air-treated controls 
(Fig. 3, A and C). These data indicate that Pim1 expression is observed in 
airway epithelial cells in mouse lung tissue and that expression is slightly 
enhanced by CS exposure.
Fig. 3: CS exposure slightly induced the expression of Pim1 kinase in the airway epithelium
Immunohistochemical analysis of the expression of Pim1 kinase in wild-type (A and C) and 
Pim1-deficient (B and D) mice in lung tissue. Using a subchronic CS exposure model, mice 
were exposed to air (A and B) or CS (C and D). Representative images are shown for lung 
tissue sections stained from n=3 mice/group. Bars indicate 90 µM.
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Inhibition of Pim1 alters the sensitivity for CS-induced loss of 
mitochondrial Ψm and cell survival
Next, we aimed to characterize the mechanism by which Pim1 deficiency 
could contribute to enhanced neutrophilic airway inflammation upon CS 
exposure. CS exposure has been shown to induce loss of mitochondrial 
Ψm, followed by necrotic cell death in airway epithelial cells in vitro [11]
[12][13][14], which has been proposed to induce a neutrophilic airway 
inflammation by the release of DAMPs [10]. Pim1 is a well-known survival 
kinase, and therefore, we first investigated whether Pim1 can augment 
survival of airway epithelial cells upon CS exposure. To this end, we used 
an in vitro approach in which we exposed BEAS-2B cells to a concentration 
series of CSE for 4 h in the presence or absence of a specific Pim1 inhibitor, 
and analyzed the effects on mitochondrial Ψm and cell death by flow 
cytometry.
Exposure of BEAS-2B cells to CSE caused a dose-dependent loss 
of mitochondrial Ψm as measured by the fluorescent probe TMRE 
(Fig. 4, A-C). Interestingly, the sensitivity of the BEAS-2B cells for the CSE-
induced loss of Ψm potential was increased by concurrent inhibition of 
Pim1 kinase activity using a specific pharmacological inhibitor (Fig. 4, A-C), 
indicating that inhibition of Pim1 sensitizes the cells to the CSE-induced 
effects on Ψm. Of note, at baseline (0% CSE), the Ψm in cells treated with 
the Pim1 inhibitor was induced by 11%. In addition to Ψm, we performed 
a next series of experiments to analyze the effects of CSE on cell survival 
using an annexinV/7-AAD staining. Here, we additionally included a 25% 
CSE group, since the results in Fig. 4A indicate that the largest difference in 
sensitivity to CSE lies in the range between 20 and 30%. Exposure of BEAS-
2B cells to CSE induced necrotic cell death (as defined by annexinV/7-AAD-
double positivity) in a dose-dependent fashion (Fig. 4, D-F). In line with 
the findings on mitochondrial Ψm, BEAS-2B cells were more sensitive for 
the induction of necrotic cell death by CSE upon inhibition of Pim1 activity 
(Fig. 4D). Because it is known that the prosurvival activity of Pim1 could be 
mediated by the phosphorylation of BAD, we measured the levels of Serine-
112-phosphorylated BAD. However, we were not able to detect differences 
in the levels of Serine-112-phosphorylated BAD upon exposure to
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CSE in the presence or absence of Pim1 activity (data not shown). In addition, 
to further support our findings in the bronchial epithelial cell line BEAS-
2B, we repeated the experiment in  primary bronchial airway epithelial 
cells. Unfortunately, we could not observe induction of cell death upon
Fig. 4: Inhibition of Pim-activity altered the sensitivity for CS-induced loss of mitochondrial 
membrane potential (Ψm) and cell survival
BEAS-2B cells were exposed to a dilution series of 0, 10, 15, 20, 30 and 40% CSE for 4 h in 
the presence or absence of the specific Pim1-inhibitor. After 4 h, the effect on mitochondrial 
Ψm was measured with the fluorescent TMRE probe by flowcytometry (A, B and C). 
BEAS-2B cells were exposed to dilution series of 0, 10, 15, 20, 25, 30 and 40% CSE for 
4 h in the presence or absence of Pim1 kinase activity, and cell death was determined 
by measuring the annexin V (AnnV) and 7-amino-actinomycyin (7-AAD) double-positive 
cells using flowcytometry (D, E and F). Both of the experiments were repeated six times. 
The dose response curves were analysed using a 2-way ANOVA, whereas the individual 
concentrations were analyzed using a paired sample t-test. The mean with SE is presented. 
* P < 0.05, ** P < 0.01 and *** P < 0.001.
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increasing concentrations of CSE up to 50% in these primary cells, 
independent of  Pim1 kinase activity (data not shown). These data suggest 
that primary bronchial airway epithelial cells are relatively resistant 
towards CSE-induced cell death, precluding confirmation of our findings 
in the BEAS-2B cell line in primary cells.
Taken together, these data show that, in the absence of Pim1 activity, 
BEAS-2B cells are more susceptible to CSE-induced loss of mitochondrial 
Ψm and cell death, indicating a direct effect of Pim1 kinase on epithelial 
cell survival.
Inhibition of Pim1 results in an increased release of DAMPs
Based on the results described above, we were interested to test how 
the prosurvival effects of Pim1 kinase relate to the neutrophilic airway 
inflammation observed in Pim1-deficient mice after exposure to CS. It is 
known that CS exposure in vitro induces airway epithelial cell necrosis [11]
[12][13][14], a form of cell death known to be able to initiate an innate 
inflammatory response by the release of DAMPs [10][15]. Therefore, we 
tested if Pim1 activity influences the release of HSP70 by BEAS-2B cells 
after exposure to CSE, since HSP70 has been shown to be released upon 
exposure to CS and to induce IL-8 expression [8][28][29]. We exposed 
BEAS-2B cells to CSE for 4 h, followed by washing to remove the CSE 
and subsequent culturing of the cells for another 20 h to allow for the 
release of HSP70. Because necrosis was readily induced in these cells at 
40% CSE, we used this dose as a positive control (Fig. 4D). We tested the 
effect of inhibition of Pim1 activity at a concentration of 15% CSE, since 
we observed this CSE concentration to be the most sensitive for the Pim1-
mediated effects on loss of mitochondrial Ψm and induction of cell death 
(Fig. 4). Remarkably, we observed a significant increase in the release of 
HSP70 in BEAS-2B cells exposed to 15% CSE in the presence of the Pim1 
inhibitor compared to vehicle control treated cells (Fig. 5).
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Fig. 5: Inhibition of Pim1-activity in BEAS-2B cells results in an increased release of HSP70
BEAS-2B cells were cultured for 20 h after exposure to CSE for 4 h in the presence or absence 
of the specific Pim1-inhibitor, and the release of HSP70 in the supernatant was measured. 
Levels of HSP70 are presented as means with SE and * P < 0.05. Data represent mean 
values of 9 independent experiments.
We have previously shown that CS exposure induces DAMP release 
in inbred mouse strains [27] and that a specific profile of DAMPs 
was associated with susceptibility to  CS-induced neutrophilic airway 
inflammation, including dsDNA and S100A8 release. To test whether a 
similar mechanism was relevant for the in vivo effects of Pim1 deficiency 
on the induction of a neutrophilic inflammation upon CS exposure, we 
aimed to study CS-induced cell death and DAMP release in vivo in the 
airway epithelium of mice. We analyzed the presence of TUNEL-positive 
cells as a marker for cell death by immunohistochemistry (IHC) staining 
in lung tissues sections of Pim1-proficient and - deficient mice exposed 
to CS or air. We were unable to detect significant numbers of apoptotic 
or necrotic cells in the tissue sections, irrespective of the experimental 
condition (Fig. 6).
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Fig. 6: CS exposure does not induce TUNEL+ cells in lung tissue of Pim1-deficient mice 
and wild-type controls
Immunohistochemical analysis of TUNEL staining in wild-type (A and C) and Pim1-deficient 
(B and D) mice in lung tissue. With the use of a subchronic CS exposure model, mice were 
exposed to air (A and B) or CS (C and D). Representative images of the 4 groups were 
shown. Positive controls for TUNEL staining are DNase I-treated lung tissue sections (E) and 
sections from thymic tissue (F).
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Therefore, we also assessed whether the levels of relevant DAMPs were 
enhanced upon CS exposure in vivo in Pim1-deficient mice exposed to CS 
in our subchronic smoke model compared to the wild-type controls. We 
detected high basal levels of HSP70 in BAL fluid of FVB/Crln mice, with no 
further induction of HSP70 upon subchronic CS exposure, independent 
of genotype of the mice (Fig. 7A). Because we previously showed that, 
while HSP70 levels in BAL are not associated with susceptibility to CS-
induced airway neutrophilia, and levels of dsDNA and S100A8 are [27], 
we also measured the levels of these DAMPs in BAL of all experimental 
groups (Fig. 7, B and C). For dsDNA, we could not observe real differences 
between the groups, irrespective of treatment or genotype (Fig. 7B). In 
contrast, the levels of S100A8 in Pim1-deficient mice exposed to CS were 
significantly increased compared to wild-type control mice exposed to CS 
(Fig. 7C).
Fig. 7: CS exposure induced enhanced release of S100A8, but not of dsDNA and HSP70
in Pim1-deficient mice
Female FVB/Nrcl mice proficient (WT) or deficient (KO) for Pim1 kinase were exposed to 
cigarette smoke or air for 4 days and sacrificed 16 h after the last smoke exposure. The 
release of HSP70 (A), dsDNA (B) and S100A8 (C) in the bronchoalveolar fluid was measured. 
Indicated values represent levels in individual mice, and the median is presented. * P < 0.05 
in Mann Whitney U-test.
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DISCUSSION
In this study, we characterized the role of Pim survival kinases in CS-induced 
neutrophilic airway inflammation. We demonstrate for the first time that 
expression of Pim1 protects against neutrophilic airway inflammation 
induced by CS exposure in mice. We observed that CS exposure induced 
expression of Pim1, but not Pim2 and Pim3 in lung tissue of mice and 
showed with IHC analysis that Pim1 expression is observed in the airway 
epithelium. Exposure of Pim1-deficient mice to CS resulted in significantly 
increased numbers of neutrophils in the BAL fluid and a trend towards 
increased levels of KC compared to wild-type controls. Given the known 
chemoattractive activity of KC for neutrophils and the strong correlation 
between KC levels and neutrophil numbers in BAL of CS-exposed mice, it 
seems reasonable to assume that the CS-induced neutrophilia involves 
KC release by tissue resident cells. To explore a potential involvement of 
Pim1-dependent cell survival, we exposed human bronchial epithelial 
cells to CSE, resulting in a dose dependent loss of Ψm potential and 
induction of necrotic cell death, which was strongly enhanced by 
concurrent inhibition of Pim1 activity. These data indicate that epithelial 
cells are more susceptible to CS-induced cell damage and death in 
the absence of Pim1 activity. This induction of necrotic cell death was 
accompanied by increased release of the DAMPs HSP70 in vitro. However, 
we were unable  to observe increased levels of HSP70 in Pim1-deficient 
mice exposed to CS, while levels of S100A8 but not dsDNA were increased 
in BAL of Pim1-deficient mice exposed to CS. Given the involvement of 
S100A8 in inducing neutrophilic inflammation in wide variety of chronic 
inflammatory disorders, it seems likely that S100A8 in BAL contributes to 
the neutrophilic airway inflammation after CS exposure in Pim1-deficient 
mice. Whether S100A8 in the in vivo CS exposure model is released after 
airway epithelial cell death or induced through another mechanism 
remains a topic for further investigation.
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Pim1 kinase was originally identified as a protooncogene, and the role 
of Pim1 kinase in cell survival in hematological malignancies is widely 
described and often associated with the BCL-2 family of pro- and anti-
apoptotic proteins [16][18][30][31]. The BCL-2 family is involved in the 
intrinsic pathway of apoptosis, which is induced upon cellular damage. 
In the intrinsic apoptotic pathway, the mitochondrial outer membrane 
is permeabilized, leading to the release of proapoptotic mediators 
(cytochrome , apoptosis-inducing factor) and the activation of caspases, 
which function in the effector phase of apoptosis [13][32]. Our observation 
that the increased sensitivity to CSE-induced loss of epithelial cell viability 
upon inhibition of Pim1 activity in vitro was associated with a reduction in 
mitochondrial Ψm, indicates the involvement of the intrinsic pathway of 
apoptosis, which can be triggered by CS exposure.
However, it is known that exposure to higher doses of CSE or 
exposure for a longer period of time mainly induces necrotic cell death 
[11][12][13][14]. The process of apoptosis is highly energy-consuming 
and depends on ATP for the execution of the apoptotic program. CS 
exposure can block the generation of ATP, thereby actively blocking 
the process of apoptosis by inhibition of caspase-3 and -9 activity and 
causing a switch toward necrosis [13][33]. Necrosis has been shown 
to induce the release of intracellular molecules into the external 
environment, some of which can serve as danger signal or DAMP [34]. 
These DAMPs can be recognized by pattern recognition receptors like the 
TLRs on innate immune cells, leading to activation of an innate immune 
response through the release of proinflammatory cytokines such as 
IL-8 and the subsequent recruitment of neutrophils [10]. We therefore 
sought to analyze DAMP release by the BEAS-2B cells in vitro and in the 
Pim1-deficient mice in vivo. Although we do observe enhanced HSP70 
release in BEAS-2B cells treated with CSE in the presence of the Pim1-
inhibitor in vitro, we do find inconsistent results in the mouse study. We 
analyzed three DAMPs in the BAL fluid of the different treatment groups: 
HSP70 (as this  was observed in the in vitro study) and two DAMPs we 
previously showed to be associated with susceptibility  to  CS-induced 
neutrophilic  airway  inflammation  in  mice  (S100A8  and  dsDNA) [27].
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The levels of HSP70 were not different between the experimental groups, 
which is in agreement with our previous findings [27]. Although we do 
observe increased levels of S100A8 in Pim1-deficient mice exposed to CS, 
we do not observe differences in dsDNA between the Pim1-deficient mice 
and the wild-type controls. This indicates that the CS-induced neutrophilic 
airway inflammation might be specifically associated with increased levels 
of S100A8, which has been shown before in mice and human [35][36]. 
Further research in Pim1-deficient mice should be performed to specific 
reveal the release of S100A8 in these mice.
The lack of consistent induction of the two DAMPs associated with 
neutrophilic airway inflammation upon CS exposure might be explained 
by the relatively late time point of analysis: 16 h after CS-exposure in 
the current study, while the previous study was performed at 2 h after 
the last CS exposure. This might result in clearance or breakdown of 
dsDNA from the airways, whereas S100A8 may retain for longer periods 
of time in the airways. In support of our interpretation, mouse bronchial 
epithelial cells have been observed to express high levels of S100A8 [36]. 
However, we cannot exclude the possibility that damage to other cells 
than airway epithelial cells contributes to this increased level of S100A8, 
since these molecules are produced by a wide range of cell types including 
neutrophils and macrophages [37]. Alternatively, it might be possible that 
the neutrophilic airway inflammation observed in Pim1-deficient mice is 
induced through another mechanism than increased susceptibility for CS-
induced cell death.
We tried to demonstrate alterations on cell survival in vivo to support 
a role for Pim1 kinase in enhancing cell viability upon CS exposure, but 
unfortunately we were unable to detect significant differences in the 
number of necrotic or apoptotic cells in lung tissue sections between 
CS exposed and air control-treated mice and between Pim1-deficient 
mice and wild-type controls. Possibly, our model is also not optimal 
for the detection of cell death, since we killed the mice at a relatively 
late time point of 16 h after the last smoke exposure. Alternatively, 
Pim1 activity modulates the response of   the   airway  epithelial  cells 
to   CS  exposure  through   the   regulation  of  innate  inflammatory
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responses, independent of the regulation of cell death. The resulting 
inflammatory response induced in the absence of Pim1 activity is 
then characterized by the release of S100A8 and KC, and induction of 
neutrophilic inflammation in the airways. Further research is needed to 
address these effects of Pim1 in more detail.
In conclusion, this study shows for the first time that Pim1 kinase plays 
an important protective role in suppression of airway neutrophilia upon 
CS exposure. Our data indicate that CS exposure in the absence of Pim1 
activity induces release of S100A8 and KC, and  initiation of an innate 
immune response characterized by a predominant neutrophilic infiltrate, 
which is of importance in the pathogenesis of COPD. The current study, 
however, does not address the role for Pim1 kinase in an experimental 
model of COPD. Therefore, it is of interest to study the role Pim1 kinase in 
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